Posted by admin
on Mar 10, 2010 in Press Release
| 0 comments
Mammotome, a division of Devicor Medical Products, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Mammotome MI (Molecular Imaging) System, used to conduct minimally invasive, vacuum-assisted breast biopsy with molecular imaging guidance. It is the first device of its kind to receive FDA clearance and it is commercially available to...